Journals / Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi / 2002 / Cilt: 7 - Sayı: 1

The role of antibiotic treatment alone for the management of Brucella endocarditis: A case report and literature review

Brucella endokarditinde sadece medikal tedavinin yeri: Bir olgu sunumu ve literatür derlemesi

Pages
63–67
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Depending on the data from the current literature and our patient we suggest that in selected patients with Brucella endocarditis who do not have congestive heart failure, valve destruction, abscess formation, or a prosthetic valve, conservative antibiotic treatment may be a valid alternative to surgery.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Endocarditis is a rare complication of brucellosis but it is the main cause of mortality in this disease.
📊
Key Findings & Data:In our literature review, we have found 14 patients with brucellosis endocarditis treated with antibiotics alone with a favorable outcome.
💡
Conclusion & Impact:Depending on the data from the current literature and our patient we suggest that in selected patients with Brucella endocarditis who do not have congestive heart failure, valve destruction, abscess formation, or a prosthetic valve, conservative antibiotic treatment may be a valid alternative to surgery.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Endokardit · bakteriyel · İlaç tedavisi

Abstract

Endocarditis is a rare complication of brucellosis but it is the main cause of mortality in this disease. The accepted treatment for Brucella endocarditis is a combination of valve replacement and antibiotics. Conservative antibiotic treatment alone is not recommended by most of the authors as it is considered ineffective and to be increasing the risk of fatality. In our literature review, we have found 14 patients with brucellosis endocarditis treated with antibiotics alone with a favorable outcome. In this report, we described a patient treated with antibiotics alone and reviewed the literature. Depending on the data from the current literature and our patient we suggest that in selected patients with Brucella endocarditis who do not have congestive heart failure, valve destruction, abscess formation, or a prosthetic valve, conservative antibiotic treatment may be a valid alternative to surgery.

Özet

Endokardit, brusellozun nadir bir komplikasyonu olmasına karşın, bu hastalığa bağlı ölümlerin ana nedenidir. Brucella endokarditinde (BE) kabul edilen etkin tedavi yaklaşımı, kapak değişimi ile antibiyotiklerin birlikte verilmesidir. Yazarların çoğu tarafından, yalnızca medikal tedavi etkisiz ve ölüm riski yüksek olduğu düşüncesiyle önerilmemektedir. Yaptığımız literatür taramasında sadece medikal tedavi ile iyileşmiş 14 BE'li olguya ulaşabildik. Bu yazıda medikal tedavi ile iyileşmiş bir BE olgusu sunularak ilgili literatür bilgileri tartışıldı. Olgumuza ve literatürde tartışılan olgulara dayanarak, kalp yetersizliği gelişmemiş, kapak destrüksiyonu ve kardiyak apse oluşumu gözlenmeyen, yapay kalp kapağı olmayan olgularda sadece ilaç tedavisinin bir seçenek olabileceğini düşündük.

🔖

Cite This Article

MERT, A., KOÇAK, F., ÖZARAS, R., TABAK, F., BİLİR, M., ÖZTÜRK, R., AKTUĞLU, Y. (2002). The role of antibiotic treatment alone for the management of Brucella endocarditis: A case report and literature review. Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi, Cilt: 7 - Sayı: 1, 63–67. https://ajindex.com/articles/224466

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. Young EJ. Brucella species. In: Mandell GL, Bennett JE, Dolin R (eds). Principles and Practice of Infectious Diseases. 5th ed. Philadelphia: Churchill-Livingstone Inc, 2000: 2386-93
  2. Jacobs F, Abramowicz D, Vereerstraeten P, Le Clere JL, Zech F, Thys JP. Brucella endocarditis: The role of com¬bined medical and surgical treatment. Rev Infect Dis 1990;12:740-4
  3. Cohen N, Golik A, Alon I, et al. Conservative treatment for Brucella endocarditis. Clin Cardiol 1997;20:291-4
  4. Peery TM, Belter LF. Brucellosis and heart disease. II. fa¬tal brucellosis: A review of the literature and report of new cases. Am J Pathol 1960;36:673-95
  5. Quinn RW, Brown JW: Bacterial endocarditis. Arch Intern Med 1954;94:679-84
  6. Hudson RA. Brucella abortus endocarditis. A case. Circulation 1957; 16:411-3
  7. Farid Z, Trabolsi B. Successful treatment of two cases of Brucella endocarditis with rifampicin. Br Med J 1985;291:110
  8. Aimer LO. A case of brucellosis complicated by endocarditis and disseminated intravascular coagulation. Acta Med Scand 1985;217:139-40
  9. Cisneros JM, Pachon J, Cuello JA, Martinez A. Brucella endocarditis cured by medical treatment. J Infect Dis 1989;160:907
  10. Al-Harthi SS. The morbidity and mortality pattern of Brucella endocarditis. Int J Cardiol 1989;25:321-4
  11. Al Mudallal DS, Mousa ARM, Marafie AA. Apyrexic Brucella melitensis aortic valve endocarditis. Trop Geogr Med 1989;41:372-6
  12. Flugelman MY, Galun E, Ben-Chetrit E, Caraco J, Rubinow A. Brucellosis in patients with heart disease: When should endocarditis be diagnosed? Cardiology 1990; 77:313-7
  13. Micozzi A, Venditti M, Gentile G, Alessandri N, Santero M, Martino P. Successful treatment of Brucella melitensis endocarditis with pefloxacin. Eur J Clin Microbiol Infect Dis 1990;9:440-2
  14. Barham WB, Church P, Brown JE, Paparello S. Misidentificatiori of Brucella species with use of rapid bacterial identification systems. Clin Infect Dis 1993;17:1068-9
  15. Çetin ET, Çoral B, Bilgiç A ve ark. Türkiye'de insanda bruselloz insidansının saptanması. Doğa-Tr J Med Sci 1990; 14:324-34
  16. Mousa ARM, Elhag KM, Khogali M, Marafie AA. The nature of human brucellosis in Kuwait: Study of 379 cases. Rev Infect Dis 1988;10:211-7
  17. Ariza J, Gudiol F, Pallares R, et al. Treatment of human brucellosis with doxycycline plus rifampin or doxycycline plus streptomycin. Ann Intern Med 1992; 117:25-30
  18. Montejo JM, Alberola I, Zarate PG, et al. Open, randomized therapeutic trial of six antimic